New Methods of Gene Transfer to the Retina
基因转移到视网膜的新方法
基本信息
- 批准号:12557145
- 负责人:
- 金额:$ 8万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Retinitis pigmentosa is a complex of hereditary progressive retinal degenerations that is nominated as the third commonest cause of legal blindness in adult population in Japan with an incidence of 1 out of 3,500 people, and therefore is an important disease in terms of the policy against blindness. Gene therapy, retinal transplantation and visual prosthesis have been currently studied by many researchers in the world, and expected to be developed as effective treatment. In this study, we investigated the technical possibility and effect of in vivo gene transfer to the retina by electroporation as a method of gene therapy for retinal degeneration. To test the technical possibility, we employed pars plana vitrectomy on the rabbit eyes to approach the retina, injected DNA solution in the subretinal space, and applied electroporation with a needle electrodes. The result indicated that this method could transfer DNA only in a small area of the retina, which might be insufficient to cause t … More herapeutic effects. It also indicated that we needed to develop another type of electrodes such as cup-shaped one. As the second part of the study, we studied the expression and effect of electroporatic gene transfer to the ocular tissue. First of all, we employed conjunctival tissue as a target of gene transfer prier to the retina, because it seemed easier to transfer DNA to the conjunctiva than to the retina. The result showed that the green fluorescent protein transferred to the conjunctiva by electroporation had been apparently expressed in the target tissue 30 days after transfer. Then we tried to transfer metalloproteinase 3 cDNA to the conjunctival flap during trabeculectomy on the rabbit eyes to examine the effect of the gene on intraocular pressure in the postoperative period. The result indicated that postoperative intraocular pressure of the eye treated with gene transfer showed as low as the eye treated by trabeculectomy with MMC, and that there was no pathological reaction in the area where DNA had been injected. All these results have suggested that we successfully transferred DNA fragments to the conjunctiva prier to the retinal, that it is possible for us to perform gene transfer to the retina using electroporation with some modification, and that gene therapy can be applied to glaucoma filtration surgery. Less
色素性视网膜炎是遗传性渐进性视网膜变性的复杂性,被提名为日本成年人口中法律失明的第三个最常见原因,其中有3500人中有1人有1人,因此,就反对失明政策而言,这是一种重要疾病。目前,世界上许多研究人员都研究了基因疗法,视网膜移植和视觉假体,并有望作为有效治疗发展。在这项研究中,我们研究了通过电穿孔转移到视网膜的技术可能性和影响,作为一种残留变性的基因治疗方法。为了测试技术的可能性,我们在兔眼上使用了PARS植物玻璃体切除术,接近视网膜,在视网膜下空间注入DNA溶液,并用针电极施加电穿孔。结果表明,该方法只能在视网膜的一小部分中传递DNA,这可能不足以引起……更多的久远效应。这也表明我们需要开发另一种类型的电极,例如杯形。作为研究的第二部分,我们研究了电基因转移到眼组织的表达和影响。首先,我们利用结膜组织作为视网膜前基因转移的靶标,因为将DNA转移到结膜上比视网膜更容易。表明,通过电穿孔转移到结膜的绿色荧光蛋白显然在转移后30天在目标组织中表达。然后,我们试图将金属蛋白酶3 cDNA转移到小梁切除术期间兔眼上的结膜皮瓣,以检查术后基因对眼内压的作用。结果表明,用基因转移治疗的眼睛的眼内压与小梁切除术用MMC处理的眼睛一样低,并且在注射DNA的区域没有病理反应。所有这些结果都表明,我们在视网膜之前成功将DNA片段转移到结膜上,因此我们有可能使用一些修饰的电穿孔将基因转移到视网膜上,并且该基因治疗可以应用于格拉糖果滤过手术。较少的
项目成果
期刊论文数量(78)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
中沢 満: "眼科診療Q&A31"加齢黄斑変性の原因遺伝子とその臨床応用の可能性(分担). 1000 (2002)
Mitsuru Nakazawa:“眼科问答31”负责年龄相关性黄斑变性的基因及其临床应用的可能性(共享)1000(2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M: "Retinal dysfunction in cancer-associated retinopathy is improved by Ca2+ anatagonist administration and dark adaptation"Investigative Ophthalmology & Visual Science. 41(10). 2589-2595
Ohguro H、Okawa K、Maeda T、Maruyama I、Maeda A、Takano Y、Nakazawa M:“通过 Ca2 拮抗剂给药和暗适应可改善癌症相关视网膜病变中的视网膜功能障碍”调查眼科
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanimoto N, et al.: "Electroretinographic findings in three family members with X-linked juvenile retinoschisis associated with a novel Pro192Thr mutation of the XLRS1 gene"Japanese Journal of Ophthalmology. 46 (5). 566-576 (2002)
Tanimoto N 等人:“三个患有 X 连锁青少年视网膜劈裂症的家庭成员的视网膜电图检查结果与 XLRS1 基因的新型 Pro192Thr 突变相关”,《日本眼科杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sekiya K, et al.: "Long-term fundus changes of fundus albipunctatus associated with mutations of the RDH5 gene"Arch Ophthalmol. in press.
Sekiya K 等人:“与 RDH5 基因突变相关的眼底白斑的长期眼底变化”Arch Ophasemol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Miyagawa Y, et al.: "Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines"Biochem. Biophys. Res. Com.. 300. 669-673 (2003)
Miyakawa Y 等人:“异常表达的恢复素在功能上与癌细胞系中的 G 蛋白偶联受体激酶相关”Biochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAZAWA Mitsuru其他文献
NAKAZAWA Mitsuru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAZAWA Mitsuru', 18)}}的其他基金
Research for new treatments for targeting photoreceptor protection
针对光感受器保护的新疗法研究
- 批准号:
24592616 - 财政年份:2012
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EFFECTS OF THE ARMS2 GENE POLYMORPHISM ON CLINICAL FEATURES OF RETINITIS PIGMENTOSA
Arms2基因多态性对色素性视网膜炎临床特征的影响
- 批准号:
21592213 - 财政年份:2009
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The effect of new medical treatment for hereditary retinal degeneration based on its molecular pathogenesis
基于遗传性视网膜变性分子发病机制的新药治疗效果
- 批准号:
14370552 - 财政年份:2002
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A Study of Molecular Pathogenesis and Treatment of Retinitis Pigmentosa and Allied Diseases
色素性视网膜炎及相关疾病的分子发病机制及治疗研究
- 批准号:
11470361 - 财政年份:1999
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Genetic Analysis of Retinitis Pigmentosa
色素性视网膜炎的分子遗传学分析
- 批准号:
09671782 - 财政年份:1997
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Biological Research for Retinitis Pigmentosa
色素性视网膜炎的分子生物学研究
- 批准号:
05454468 - 财政年份:1993
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Molecular Biological Research for Retinitis Pigmentosa
色素性视网膜炎的分子生物学研究
- 批准号:
03454411 - 财政年份:1991
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Research for Anti-Retinal Antibody in Retinal Disorders
抗视网膜抗体在视网膜疾病中的研究
- 批准号:
63480389 - 财政年份:1988
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
熏蒸剂处理土壤中胞内与胞外抗生素抗性基因赋存规律及水平转移机制
- 批准号:42307377
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
超表达木聚糖阿拉伯糖转移酶基因促进水稻光合作用和产量提高的生理机制研究
- 批准号:32372218
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
质粒介导下抗生素抗性基因在氮素转化功能菌中的水平转移机理研究
- 批准号:32360316
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
组蛋白乙酰转移酶P300招募TET1共同调控ZNF334基因表达在结直肠癌生长中的机制研究
- 批准号:82302970
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基因组导向挖掘的[4,8]双环杂萜类活性成分及其关键异戊烯基转移酶的催化机制研究
- 批准号:82304346
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Genome Editing Therapy for Usher Syndrome Type 3
针对 3 型亚瑟综合症的基因组编辑疗法
- 批准号:
10759804 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Visual Cortical Plasticity and the Implications for Sight Restoration Technologies
视觉皮层可塑性及其对视力恢复技术的影响
- 批准号:
10480903 - 财政年份:2020
- 资助金额:
$ 8万 - 项目类别:
Visual Cortical Plasticity and the Implications for Sight Restoration Technologies
视觉皮层可塑性及其对视力恢复技术的影响
- 批准号:
10065255 - 财政年份:2020
- 资助金额:
$ 8万 - 项目类别:
Visual Cortical Plasticity and the Implications for Sight Restoration Technologies
视觉皮层可塑性及其对视力恢复技术的影响
- 批准号:
10411891 - 财政年份:2020
- 资助金额:
$ 8万 - 项目类别: